Volitionrx (VNRX) Capital Expenditures Growth (5y) (2016 - 2025)
Volitionrx (VNRX) Capital Expenditures Growth (5y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.51 Bn | 174.22 Bn | 6.27 Bn |
| 2 | Stryker | 128.20 Bn | 125.32 Bn | 3.81 Bn |
| 3 | Medtronic | 107.69 Bn | 98.47 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.05 Bn | 66.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.52 Bn | 43.85 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.46 Bn | 26.17 Bn | 1.98 Bn |
| 7 | Dexcom | 28.25 Bn | 27.13 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.73 Bn | 26.15 Bn | - |
| 9 | Koninklijke Philips | 25.31 Bn | 22.19 Bn | 2.07 Bn |
| 10 | Volitionrx | 92,854.63 | -1.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -61.29% |
| Jun 30, 2025 | -39.25% |
| Mar 31, 2025 | 14.93% |
| Dec 31, 2024 | 19.90% |
| Sep 30, 2024 | 25.51% |
| Jun 30, 2024 | 16.50% |
| Mar 31, 2024 | 19.59% |
| Sep 30, 2023 | -53.96% |
| Jun 30, 2023 | 36.26% |
| Dec 31, 2022 | 46.77% |
| Sep 30, 2022 | 25.31% |
| Jun 30, 2022 | 8.50% |
| Mar 31, 2022 | -32.28% |
| Dec 31, 2021 | -16.96% |
| Sep 30, 2021 | 46.45% |
| Dec 31, 2020 | 166.93% |
| Sep 30, 2020 | 70.97% |
| Jun 30, 2020 | 84.05% |
| Mar 31, 2020 | -82.18% |
| Dec 31, 2019 | -97.70% |